UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~November~~December 11, 2019

VITAMIN SHOPPE, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-34507

11-3664322

(State or other jurisdiction of

incorporation or organization)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

300 Harmon Meadow Blvd.

Secaucus, New Jersey 07094

(Address of principal executive office)

Registrant’s telephone number, including area code: (201) 868-5959

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☒☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, $0.01 par value

per share

VSI

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 15.0107. ~~Entry~~Submission ~~into~~of Matters to a ~~Material~~Vote ~~Definitive~~of ~~Agreement~~Security Holders.

AsOn ~~previously disclosed on August~~December 811, 2019, Vitamin Shoppe, Inc., a Delaware corporation (the “Company”), ~~entered~~held ~~into~~a anspecial meeting of the Company’s stockholders (the “Special Meeting”) to consider certain proposals related to the Agreement and Plan of Merger (as ~~may~~ be amended from time to time, the “Merger Agreement”), dated as of August 7, 2019, ~~with~~by ~~Franchise~~and ~~Group,~~among ~~Inc.~~the ~~(formerly~~Company, ~~known~~Franchise ~~as Liberty Tax~~Group, Inc.), a Delaware corporation (“Parent”), and, Valor Acquisition, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent (“Merger Sub”)., ~~Capitalized~~pursuant ~~terms~~to ~~used~~which ~~herein~~the ~~but~~Company ~~not~~will ~~otherwise~~merge ~~defined~~with ~~have~~and ~~the~~into ~~meaning~~Merger Sub ~~ascribed~~(the to“Merger”), ~~such~~with ~~terms~~Merger inSub surviving the Merger ~~Agreement~~.

OnAs of the close of business on November 114, 2019, the ~~Company,~~record ~~Parent~~date ~~and~~for ~~Merger~~the ~~Sub~~Special Meeting, ~~entered~~there ~~into~~were a24,101,288 ~~First~~shares ~~Amendment~~of tocommon ~~Agreement~~stock, ~~and~~par ~~Plan~~value $0.01 per share, of ~~Merger~~the Company (the “~~Amendment~~Common Shares”) outstanding, each of which, ~~among~~was ~~other~~entitled ~~things,~~to ~~provides~~one ~~that~~vote with respect to each proposal considered at the ~~Company~~Special ~~will~~Meeting. ~~merge~~At the ~~with~~Special ~~and~~Meeting, ~~into~~a ~~Merger~~total ~~Sub~~of 20,833,506 ~~with~~Common ~~Merger~~Shares, ~~Sub~~representing ~~continuing~~approximately as86.44% of the ~~Surviving~~outstanding ~~Company~~Common ~~and~~Shares aentitled ~~wholly~~to ~~owned~~vote, ~~subsidiary~~were ofpresent ~~Parent~~in person or by proxy, constituting a quorum to conduct business.

~~The~~At ~~foregoing~~the ~~description~~Special ofMeeting, the ~~Amendment~~proposals ~~does~~described ~~not~~below ~~purport~~were toconsidered, beeach ~~complete~~of ~~and~~which is ~~subject~~further ~~to,~~described ~~and qualified~~ in ~~its~~the ~~entirety~~Company’s ~~by,~~definitive ~~the~~proxy ~~full text~~statement offiled with the ~~Amendment,~~U.S. aSecurities ~~copy~~and ofExchange ~~which~~Commission isand ~~attached~~first ~~hereto~~mailed asto ~~Exhibit~~shareholders ~~2.1~~on ~~and~~November 12, is2019, ~~incorporated~~as ~~herein~~amended byor ~~reference~~supplemented infrom ~~its~~time ~~entirety~~to time.

~~Item~~The ~~9.01~~final ~~Financial~~voting ~~Statements~~results ~~and~~for ~~Exhibits~~each proposal are set forth below.

~~(d) Exhibits~~1. Proposal to adopt the Merger Agreement:

The following exhibits are filed as part of this report:


For	Against	Abstain	Broker Non-Votes
20,789,494	43,531	481	—

Exhibit		Description
2.1		First Amendment to Agreement and Plan of Merger, dated as of November 11, 2019, by and among Vitamin Shoppe, Inc., Franchise Group, Inc. (formerly known as Liberty Tax, Inc.), and Valor Acquisition, LLC.

2. Proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the Company’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement:

Additional Information and Where to Find It


For	Against	Abstain	Broker Non-Votes
18,963,294	1,655,575	214,637	—

~~In connection with the proposed transaction, the Company has filed with the United States Securities and Exchange Commission (the “SEC”) a preliminary proxy statement and other relevant documents~~3. Proposal ~~This communication does not constitute an offer~~ to ~~sell~~approve ~~or the solicitation of an offer to buy~~ any ~~securities~~adjournment ~~or a solicitation~~ of ~~any vote or approval, and is not a substitute for~~ the ~~proxy statement~~Special orMeeting ~~any other document that the Company may file with the SEC or send~~ to ~~its~~solicit ~~stockholders~~additional inproxies ~~connection~~if ~~with~~there ~~the~~are ~~proposed transaction. BEFORE MAKING ANY VOTING DECISION, COMPANY STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING~~insufficient ~~ANY~~votes AMENDMENTS OR SUPPLEMENTS THERETO) CAREFULLY AND IN ITS ENTIRETY, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE THEREIN, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES TO THE PROPOSED TRANSACTION. Investors and security holders will be able to ~~obtain~~adopt ~~a copy of~~ the ~~proxy~~Merger ~~statement~~Agreement ~~and other documents filed by the Company with the SEC free of charge~~ at the ~~SEC’s~~Special ~~website, http~~Meeting:~~//www.sec.gov,~~ ~~and the Company’s website, http://investors.vitaminshoppe.com.~~

~~Certain~~Because there were sufficient votes at the Special Meeting to approve the proposal regarding ~~Information~~the ~~Regarding~~Merger ~~Participants~~Agreement, this third proposal was not submitted to the Company’s stockholders for approval at the Special Meeting.

~~The~~No ~~Company~~other ~~and its directors and certain executive officers and employees may be deemed to be participants in the~~business ~~solicitation~~properly ofcame ~~proxies~~before ~~from~~ the ~~holders~~Special ~~of Company common stock in respect of the proposed transaction~~Meeting. Information about the directors and executive officers of the Company is set forth in the Company’s Annual Report on Form 10-K for the year ended December 29, 2018, filed with the SEC on February 26, 2018, and proxy statement

2SIGNATURES

~~for~~Pursuant ~~its~~to ~~2019~~the ~~annual~~requirements ~~meeting~~ of ~~stockholders, filed with~~ the ~~SEC~~Securities onExchange ~~April 25,~~Act ~~2019. Additional information regarding potential participants in the proxy solicitation and a description~~ of ~~their~~ ~~direct and indirect interests~~1934, ~~by security holdings or otherwise, will be contained in~~ the ~~proxy~~registrant ~~statement~~has ~~and~~duly ~~other~~caused ~~relevant~~this ~~documents~~report to be ~~filed~~signed byon ~~the~~its ~~Company~~behalf ~~with~~by the ~~SEC~~undersigned hereunto induly ~~respect of the proposed transaction when they become available~~authorized.

~~Cautionary~~Vitamin ~~Statement~~Shoppe, ~~Regarding~~Inc. ~~Forward-Looking~~By: ~~Statements~~/s/ David M. Kastin David M. Kastin Senior Vice President, General Counsel and Corporate Secretary

~~This~~Date: ~~communication contains “forward-looking” statements within the meaning of Section~~December ~~27A of the Securities Act of 1933~~11, as2019 amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, those that contain, or are identified by, words such as “outlook”, “guidance”, “believes”, “expects”, “potential”, “continues”, “may”, “will”, “should”, “predicts”, “intends”, “plans”, “estimates”, “anticipates”, “could” or the negative version of these words or other comparable words. Forward-looking statements may include, but are not limited to, statements relating to the proposed transaction with Parent. These statements are subject to various risks and uncertainties, many of which are outside of the Company’s control, including, among others, the risk that the proposed transaction may not be completed in a timely manner or at all, which may adversely affect the Company’s business and the price of the Company’s common stock; risks related to the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement; the failure to obtain the requisite stockholder approval of the proposed transaction or the failure to satisfy any of the other conditions to the completion of the proposed transaction; the effect of the announcement or pendency of the proposed transaction on the ability of the Company to retain and hire key personnel and maintain relationships with its customers, suppliers, partners and others with whom it does business, or on its operating results and business generally; risks associated with the diversion of management’s attention from ongoing business operations due to the proposed transaction; legal proceedings related to the proposed transaction; uncertainties as to Parent’s ability to obtain financing in order to consummate the proposed transaction; and costs, charges or expenses resulting from the proposed transaction. Actual results may differ materially from anticipated results or outcomes discussed in any forward-looking statement. Additional factors that could cause actual results to differ materially from forward-looking statements include the strength of the economy; changes in the overall level of consumer spending; the performance of the Company’s products within the prevailing retail environment; implementation of the Company’s strategy; compliance with regulations, certifications and best practices with respect to the development, manufacture, sale and marketing of the Company’s products; management changes; maintaining appropriate levels of inventory; changes in tax policy; ecommerce relationships; disruptions of manufacturing, warehouse or distribution facilities or information systems; regulatory environment and other specific factors discussed herein and in other SEC filings by the Company (including the Company’s reports on Forms 10-K and 10-Q filed with the SEC). The Company believes that all forward-looking statements are based on reasonable assumptions when made; however, the Company cautions that it is impossible to predict actual results or outcomes or the effects of risks, uncertainties or other factors on anticipated results or outcomes with certainty and that, accordingly, one should not place undue reliance on these statements. Forward-looking statements speak only as of the date when made and the Company undertakes no obligation to update these statements in light of subsequent events or developments.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

VITAMIN SHOPPE, INC.

Date: November 12, 2019

/s/ David M. Kastin

David M. Kastin

Senior Vice President, General Counsel and Corporate Secretary

Filing Compare · Vitamin Shoppe, Inc.